312 related articles for article (PubMed ID: 15618016)
1. ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion.
Beck V; Herold H; Benge A; Luber B; Hutzler P; Tschesche H; Kessler H; Schmitt M; Geppert HG; Reuning U
Int J Biochem Cell Biol; 2005 Mar; 37(3):590-603. PubMed ID: 15618016
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.
Ruseva Z; Geiger PX; Hutzler P; Kotzsch M; Luber B; Schmitt M; Gross E; Reuning U
Exp Cell Res; 2009 Jun; 315(10):1759-71. PubMed ID: 19371633
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction.
Hapke S; Kessler H; Luber B; Benge A; Hutzler P; Höfler H; Schmitt M; Reuning U
Biol Chem; 2003 Jul; 384(7):1073-83. PubMed ID: 12956424
[TBL] [Abstract][Full Text] [Related]
4. ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation.
Chen Q; Meng LH; Zhu CH; Lin LP; Lu H; Ding J
Int J Biochem Cell Biol; 2008; 40(10):2164-73. PubMed ID: 18387333
[TBL] [Abstract][Full Text] [Related]
5. Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes.
Lee HD; Koo BH; Kim YH; Jeon OH; Kim DS
FASEB J; 2012 Jul; 26(7):3084-95. PubMed ID: 22505472
[TBL] [Abstract][Full Text] [Related]
6. Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription.
Lössner D; Abou-Ajram C; Benge A; Aumercier M; Schmitt M; Reuning U
J Cell Physiol; 2009 Aug; 220(2):367-75. PubMed ID: 19334037
[TBL] [Abstract][Full Text] [Related]
7. Expression of ADAM15 in lung carcinomas.
Schütz A; Härtig W; Wobus M; Grosche J; Wittekind Ch; Aust G
Virchows Arch; 2005 Apr; 446(4):421-9. PubMed ID: 15756594
[TBL] [Abstract][Full Text] [Related]
8. RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.
Georgoulis A; Havaki S; Drosos Y; Goutas N; Vlachodimitropoulos D; Aleporou-Marinou V; Kittas C; Marinos E; Kouloukoussa M
Ultrastruct Pathol; 2012 Dec; 36(6):387-99. PubMed ID: 23181508
[TBL] [Abstract][Full Text] [Related]
9. Integrin αvβ3 promotes vitronectin gene expression in human ovarian cancer cells by implicating rel transcription factors.
Reuning U
J Cell Biochem; 2011 Jul; 112(7):1909-19. PubMed ID: 21433063
[TBL] [Abstract][Full Text] [Related]
10. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3.
Zhang XP; Kamata T; Yokoyama K; Puzon-McLaughlin W; Takada Y
J Biol Chem; 1998 Mar; 273(13):7345-50. PubMed ID: 9516430
[TBL] [Abstract][Full Text] [Related]
11. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells.
Lössner D; Abou-Ajram C; Benge A; Reuning U
Int J Biochem Cell Biol; 2008; 40(12):2746-61. PubMed ID: 18577466
[TBL] [Abstract][Full Text] [Related]
12. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Fujita M; Takada YK; Takada Y
PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099
[TBL] [Abstract][Full Text] [Related]
13. ADAM15 overexpression in NIH3T3 cells enhances cell-cell interactions.
Herren B; Garton KJ; Coats S; Bowen-Pope DF; Ross R; Raines EW
Exp Cell Res; 2001 Nov; 271(1):152-60. PubMed ID: 11697891
[TBL] [Abstract][Full Text] [Related]
14. Vitronectin-αvβ3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells.
Pola C; Formenti SC; Schneider RJ
Cancer Res; 2013 Jul; 73(14):4571-8. PubMed ID: 23722547
[TBL] [Abstract][Full Text] [Related]
15. Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion.
Villard V; Kalyuzhniy O; Riccio O; Potekhin S; Melnik TN; Kajava AV; Rüegg C; Corradin G
J Pept Sci; 2006 Mar; 12(3):206-12. PubMed ID: 16103993
[TBL] [Abstract][Full Text] [Related]
16. Interaction of metargidin (ADAM-15) with alphavbeta3 and alpha5beta1 integrins on different haemopoietic cells.
Nath D; Slocombe PM; Stephens PE; Warn A; Hutchinson GR; Yamada KM; Docherty AJ; Murphy G
J Cell Sci; 1999 Feb; 112 ( Pt 4)():579-87. PubMed ID: 9914169
[TBL] [Abstract][Full Text] [Related]
17. Cell surface overexpression of alphavbeta5 integrin impedes alphavbeta3-mediated migration of the human ovarian adenocarcinoma cell line IGROV1.
Maubant S; Leroy-Dudal J; Carreiras F; Deslandes E; Duigou F; Staedel C; Gauduchon P
Cell Biol Int; 2007 Feb; 31(2):109-18. PubMed ID: 17074516
[TBL] [Abstract][Full Text] [Related]
18. ADAM15 is an adherens junction molecule whose surface expression can be driven by VE-cadherin.
Ham C; Levkau B; Raines EW; Herren B
Exp Cell Res; 2002 Oct; 279(2):239-47. PubMed ID: 12243749
[TBL] [Abstract][Full Text] [Related]
19. ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation.
Langer H; May AE; Bültmann A; Gawaz M
Thromb Haemost; 2005 Sep; 94(3):555-61. PubMed ID: 16268472
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing of KAI1 abrogates its tumor-suppressive effects on integrin αvβ3-mediated ovarian cancer biology.
Upheber S; Karle A; Miller J; Schlaugk S; Gross E; Reuning U
Cell Signal; 2015 Mar; 27(3):652-62. PubMed ID: 25435431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
